Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.
The latest research study released by Market IntelliX evaluates market size and forecasts of Clinical Diagnostics PCR in Global, including the following market information:
Global Clinical Diagnostics PCR Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Clinical Diagnostics PCR market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Infectious Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clinical Diagnostics PCR include Abbott Laboratories, Agilent Technologies Inc., Abbott, Asuragen, Inc., Danaher, Biocartis Group Nv, Biomérieux, Bio-Rad Laboratories, Inc. and Genmark Diagnostics, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Clinical Diagnostics PCR companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Clinical Diagnostics PCR Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Clinical Diagnostics PCR Market Segment Percentages, by Type, 2021 (%)
Infectious Disease
Cancer
Cardiovascular
Genetic
Others
Global Clinical Diagnostics PCR Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Clinical Diagnostics PCR Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Clinical Diagnostics PCR Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Clinical Diagnostics PCR Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Diagnostics PCR revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Clinical Diagnostics PCR revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Abbott Laboratories
Agilent Technologies Inc.
Abbott
Asuragen, Inc.
Danaher
Biocartis Group Nv
Biomérieux
Bio-Rad Laboratories, Inc.
Genmark Diagnostics, Inc.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience, Inc.
Qiagen N.V.
Quantumdx Group
Quidel, Inc.
Roche
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Clinical Diagnostics PCR Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Clinical Diagnostics PCR Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Clinical Diagnostics PCR Overall Market Size
2.1 Global Clinical Diagnostics PCR Market Size: 2021 VS 2028
2.2 Global Clinical Diagnostics PCR Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical Diagnostics PCR Players in Global Market
3.2 Top Global Clinical Diagnostics PCR Companies Ranked by Revenue
3.3 Global Clinical Diagnostics PCR Revenue by Companies
3.4 Top 3 and Top 5 Clinical Diagnostics PCR Companies in Global Market, by Revenue in 2021
3.5 Global Companies Clinical Diagnostics PCR Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Diagnostics PCR Players in Global Market
3.6.1 List of Global Tier 1 Clinical Diagnostics PCR Companies
3.6.2 List of Global Tier 2 and Tier 3 Clinical Diagnostics PCR Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Clinical Diagnostics PCR Market Size Markets, 2021 & 2028
4.1.2 Infectious Disease
4.1.3 Cancer
4.1.4 Cardiovascular
4.1.5 Genetic
4.1.6 Others
4.2 By Type - Global Clinical Diagnostics PCR Revenue & Forecasts
4.2.1 By Type - Global Clinical Diagnostics PCR Revenue, 2017-2022
4.2.2 By Type - Global Clinical Diagnostics PCR Revenue, 2023-2028
4.2.3 By Type - Global Clinical Diagnostics PCR Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Clinical Diagnostics PCR Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Clinical Diagnostics PCR Revenue & Forecasts
5.2.1 By Application - Global Clinical Diagnostics PCR Revenue, 2017-2022
5.2.2 By Application - Global Clinical Diagnostics PCR Revenue, 2023-2028
5.2.3 By Application - Global Clinical Diagnostics PCR Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Clinical Diagnostics PCR Market Size, 2021 & 2028
6.2 By Region - Global Clinical Diagnostics PCR Revenue & Forecasts
6.2.1 By Region - Global Clinical Diagnostics PCR Revenue, 2017-2022
6.2.2 By Region - Global Clinical Diagnostics PCR Revenue, 2023-2028
6.2.3 By Region - Global Clinical Diagnostics PCR Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Clinical Diagnostics PCR Revenue, 2017-2028
6.3.2 US Clinical Diagnostics PCR Market Size, 2017-2028
6.3.3 Canada Clinical Diagnostics PCR Market Size, 2017-2028
6.3.4 Mexico Clinical Diagnostics PCR Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Clinical Diagnostics PCR Revenue, 2017-2028
6.4.2 Germany Clinical Diagnostics PCR Market Size, 2017-2028
6.4.3 France Clinical Diagnostics PCR Market Size, 2017-2028
6.4.4 U.K. Clinical Diagnostics PCR Market Size, 2017-2028
6.4.5 Italy Clinical Diagnostics PCR Market Size, 2017-2028
6.4.6 Russia Clinical Diagnostics PCR Market Size, 2017-2028
6.4.7 Nordic Countries Clinical Diagnostics PCR Market Size, 2017-2028
6.4.8 Benelux Clinical Diagnostics PCR Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Clinical Diagnostics PCR Revenue, 2017-2028
6.5.2 China Clinical Diagnostics PCR Market Size, 2017-2028
6.5.3 Japan Clinical Diagnostics PCR Market Size, 2017-2028
6.5.4 South Korea Clinical Diagnostics PCR Market Size, 2017-2028
6.5.5 Southeast Asia Clinical Diagnostics PCR Market Size, 2017-2028
6.5.6 India Clinical Diagnostics PCR Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Clinical Diagnostics PCR Revenue, 2017-2028
6.6.2 Brazil Clinical Diagnostics PCR Market Size, 2017-2028
6.6.3 Argentina Clinical Diagnostics PCR Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Clinical Diagnostics PCR Revenue, 2017-2028
6.7.2 Turkey Clinical Diagnostics PCR Market Size, 2017-2028
6.7.3 Israel Clinical Diagnostics PCR Market Size, 2017-2028
6.7.4 Saudi Arabia Clinical Diagnostics PCR Market Size, 2017-2028
6.7.5 UAE Clinical Diagnostics PCR Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Clinical Diagnostics PCR Major Product Offerings
7.1.4 Abbott Laboratories Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Agilent Technologies Inc.
7.2.1 Agilent Technologies Inc. Corporate Summary
7.2.2 Agilent Technologies Inc. Business Overview
7.2.3 Agilent Technologies Inc. Clinical Diagnostics PCR Major Product Offerings
7.2.4 Agilent Technologies Inc. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.2.5 Agilent Technologies Inc. Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Clinical Diagnostics PCR Major Product Offerings
7.3.4 Abbott Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 Asuragen, Inc.
7.4.1 Asuragen, Inc. Corporate Summary
7.4.2 Asuragen, Inc. Business Overview
7.4.3 Asuragen, Inc. Clinical Diagnostics PCR Major Product Offerings
7.4.4 Asuragen, Inc. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.4.5 Asuragen, Inc. Key News
7.5 Danaher
7.5.1 Danaher Corporate Summary
7.5.2 Danaher Business Overview
7.5.3 Danaher Clinical Diagnostics PCR Major Product Offerings
7.5.4 Danaher Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.5.5 Danaher Key News
7.6 Biocartis Group Nv
7.6.1 Biocartis Group Nv Corporate Summary
7.6.2 Biocartis Group Nv Business Overview
7.6.3 Biocartis Group Nv Clinical Diagnostics PCR Major Product Offerings
7.6.4 Biocartis Group Nv Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.6.5 Biocartis Group Nv Key News
7.7 Biomérieux
7.7.1 Biomérieux Corporate Summary
7.7.2 Biomérieux Business Overview
7.7.3 Biomérieux Clinical Diagnostics PCR Major Product Offerings
7.7.4 Biomérieux Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.7.5 Biomérieux Key News
7.8 Bio-Rad Laboratories, Inc.
7.8.1 Bio-Rad Laboratories, Inc. Corporate Summary
7.8.2 Bio-Rad Laboratories, Inc. Business Overview
7.8.3 Bio-Rad Laboratories, Inc. Clinical Diagnostics PCR Major Product Offerings
7.8.4 Bio-Rad Laboratories, Inc. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.8.5 Bio-Rad Laboratories, Inc. Key News
7.9 Genmark Diagnostics, Inc.
7.9.1 Genmark Diagnostics, Inc. Corporate Summary
7.9.2 Genmark Diagnostics, Inc. Business Overview
7.9.3 Genmark Diagnostics, Inc. Clinical Diagnostics PCR Major Product Offerings
7.9.4 Genmark Diagnostics, Inc. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.9.5 Genmark Diagnostics, Inc. Key News
7.10 Hologic, Inc.
7.10.1 Hologic, Inc. Corporate Summary
7.10.2 Hologic, Inc. Business Overview
7.10.3 Hologic, Inc. Clinical Diagnostics PCR Major Product Offerings
7.10.4 Hologic, Inc. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.10.5 Hologic, Inc. Key News
7.11 Luminex Corporation
7.11.1 Luminex Corporation Corporate Summary
7.11.2 Luminex Corporation Business Overview
7.11.3 Luminex Corporation Clinical Diagnostics PCR Major Product Offerings
7.11.4 Luminex Corporation Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.11.5 Luminex Corporation Key News
7.12 Meridian Bioscience, Inc.
7.12.1 Meridian Bioscience, Inc. Corporate Summary
7.12.2 Meridian Bioscience, Inc. Business Overview
7.12.3 Meridian Bioscience, Inc. Clinical Diagnostics PCR Major Product Offerings
7.12.4 Meridian Bioscience, Inc. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.12.5 Meridian Bioscience, Inc. Key News
7.13 Qiagen N.V.
7.13.1 Qiagen N.V. Corporate Summary
7.13.2 Qiagen N.V. Business Overview
7.13.3 Qiagen N.V. Clinical Diagnostics PCR Major Product Offerings
7.13.4 Qiagen N.V. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.13.5 Qiagen N.V. Key News
7.14 Quantumdx Group
7.14.1 Quantumdx Group Corporate Summary
7.14.2 Quantumdx Group Business Overview
7.14.3 Quantumdx Group Clinical Diagnostics PCR Major Product Offerings
7.14.4 Quantumdx Group Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.14.5 Quantumdx Group Key News
7.15 Quidel, Inc.
7.15.1 Quidel, Inc. Corporate Summary
7.15.2 Quidel, Inc. Business Overview
7.15.3 Quidel, Inc. Clinical Diagnostics PCR Major Product Offerings
7.15.4 Quidel, Inc. Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.15.5 Quidel, Inc. Key News
7.16 Roche
7.16.1 Roche Corporate Summary
7.16.2 Roche Business Overview
7.16.3 Roche Clinical Diagnostics PCR Major Product Offerings
7.16.4 Roche Clinical Diagnostics PCR Revenue in Global Market (2017-2022)
7.16.5 Roche Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Clinical Diagnostics PCR Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|